← Leaderboards
Zelin Sheng
Trim-Edicine, Inc.
$456,130
Attributed
$456,130
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2013–14$500K$375K$250K$125K$0
'13
'14
Funding mix
By agency
NIH$456,130 · 2
By mechanism
R43$456,130 · 2
Top collaborators
No co-investigators on record.
Most similar at Trim-Edicine, Inc.
Same institution · by research overlap
- Tao Tan$4,218,311
- Norio Takizawa$1,714,520
Others in their field
Top investigators on “Adjuvant”
- Lawrence Corey · Fred Hutchinson Cancer Center$377,142,999
- Norman Wolmark · Nsabp Foundation, Inc.$267,141,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$167,183,168
- David Heimbrook · Leidos Biomedical Research, Inc.$151,668,128
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$131,206,481
- Peter B. Gilbert · Fred Hutchinson Cancer Center$117,668,001
Research focus
AdjuvantAnimal ModelAreaBiologicalBiological PreservationBlood CirculationBody SystemCell MembraneCellsCell SurvivalChemistryClinical DataClinical ResearchClinical TrialsCommercializationContractsDrug FormulationsEfficacy TestingEx Vivo PerfusionFailure (Biologic Function)FallsFamily SuidaeFutureAcute Myocardial Infarction